168 related articles for article (PubMed ID: 27523481)
21. Kinetic analysis of human and canine P-glycoprotein-mediated drug transport in MDR1-MDCK cell model: approaches to reduce false-negative substrate classification.
Li J; Wang Y; Hidalgo IJ
J Pharm Sci; 2013 Sep; 102(9):3436-46. PubMed ID: 23558561
[TBL] [Abstract][Full Text] [Related]
22. [Transplacental transport mechanisms of drugs for transplacental treatment of fetal tachyarrhythmia of MDCKII/MDCKII-BCRP cell line].
Wang W; Zhao JJ; Wang T; Wang L; Jiang XH
Yao Xue Xue Bao; 2015 Mar; 50(3):305-11. PubMed ID: 26118109
[TBL] [Abstract][Full Text] [Related]
23. Improvement of Workflows and Assay Reproducibility by The Introduction of "Assay-Ready" Culturing of MDCK Cells for Transport Studies.
Muschong P; Jin L; Schejbal J; Mezler M; Weinheimer M
Pharm Res; 2023 May; 40(5):1259-1270. PubMed ID: 36977814
[TBL] [Abstract][Full Text] [Related]
24. Both P-gp and MRP2 mediate transport of Lopinavir, a protease inhibitor.
Agarwal S; Pal D; Mitra AK
Int J Pharm; 2007 Jul; 339(1-2):139-47. PubMed ID: 17451894
[TBL] [Abstract][Full Text] [Related]
25. Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles.
Norouzi M; Yathindranath V; Thliveris JA; Kopec BM; Siahaan TJ; Miller DW
Sci Rep; 2020 Jul; 10(1):11292. PubMed ID: 32647151
[TBL] [Abstract][Full Text] [Related]
26. Differences in the expression of endogenous efflux transporters in MDR1-transfected versus wildtype cell lines affect P-glycoprotein mediated drug transport.
Kuteykin-Teplyakov K; Luna-Tortós C; Ambroziak K; Löscher W
Br J Pharmacol; 2010 Jul; 160(6):1453-63. PubMed ID: 20590635
[TBL] [Abstract][Full Text] [Related]
27. Investigation of MDR1-overexpressing cell lines to derive a quantitative prediction approach for brain disposition using in vitro efflux activities.
Sato S; Tohyama K; Kosugi Y
Eur J Pharm Sci; 2020 Jan; 142():105119. PubMed ID: 31682973
[TBL] [Abstract][Full Text] [Related]
28. A microfluidic dual gradient generator for conducting cell-based drug combination assays.
Kilinc D; Schwab J; Rampini S; Ikpekha OW; Thampi A; Blasiak A; Li P; Schwamborn R; Kolch W; Matallanas D; Lee GU
Integr Biol (Camb); 2016 Jan; 8(1):39-49. PubMed ID: 26569638
[TBL] [Abstract][Full Text] [Related]
29. Protein Expression and Functional Relevance of Efflux and Uptake Drug Transporters at the Blood-Brain Barrier of Human Brain and Glioblastoma.
Bao X; Wu J; Xie Y; Kim S; Michelhaugh S; Jiang J; Mittal S; Sanai N; Li J
Clin Pharmacol Ther; 2020 May; 107(5):1116-1127. PubMed ID: 31664714
[TBL] [Abstract][Full Text] [Related]
30. Complete Knockout of Endogenous Mdr1 (Abcb1) in MDCK Cells by CRISPR-Cas9.
Simoff I; Karlgren M; Backlund M; Lindström AC; Gaugaz FZ; Matsson P; Artursson P
J Pharm Sci; 2016 Feb; 105(2):1017-1021. PubMed ID: 26869442
[TBL] [Abstract][Full Text] [Related]
31. Multidrug resistance-associated protein 2 is involved in the efflux of Aconitum alkaloids determined by MRP2-MDCKII cells.
Dai P; Zhu L; Yang X; Zhao M; Shi J; Wang Y; Lu L; Liu Z
Life Sci; 2015 Apr; 127():66-72. PubMed ID: 25744397
[TBL] [Abstract][Full Text] [Related]
32. Assessment of metabolism-dependent drug efficacy and toxicity on a multilayer organs-on-a-chip.
Li Z; Guo Y; Yu Y; Xu C; Xu H; Qin J
Integr Biol (Camb); 2016 Oct; 8(10):1022-1029. PubMed ID: 27605158
[TBL] [Abstract][Full Text] [Related]
33. Microfabricated devices for enhanced bioadhesive drug delivery: attachment to and small-molecule release through a cell monolayer under flow.
Ainslie KM; Lowe RD; Beaudette TT; Petty L; Bachelder EM; Desai TA
Small; 2009 Dec; 5(24):2857-63. PubMed ID: 19787677
[TBL] [Abstract][Full Text] [Related]
34. A perfusable 3D cell-matrix tissue culture chamber for in situ evaluation of nanoparticle vehicle penetration and transport.
Ng CP; Pun SH
Biotechnol Bioeng; 2008 Apr; 99(6):1490-501. PubMed ID: 17969174
[TBL] [Abstract][Full Text] [Related]
35. A simple microfluidic device for live-imaging of the vertical section of epithelial cells.
Araki S; Nakano M; Tsugane M; Sunaga F; Hattori M; Nakano M; Nagai T; Suzuki H
Analyst; 2020 Jan; 145(2):667-674. PubMed ID: 31799546
[TBL] [Abstract][Full Text] [Related]
36. Microvilli Morphology Can Affect Efflux Active P-Glycoprotein in Confluent MDCKII -hMDR1-NKI and Caco-2 Cell Monolayers.
Meng Z; Le Marchand S; Agnani D; Szapacs M; Ellens H; Bentz J
Drug Metab Dispos; 2017 Feb; 45(2):145-151. PubMed ID: 27856525
[TBL] [Abstract][Full Text] [Related]
37. Controlled Drug Release and Chemotherapy Response in a Novel Acoustofluidic 3D Tumor Platform.
Zervantonakis IK; Arvanitis CD
Small; 2016 May; 12(19):2616-26. PubMed ID: 27031786
[TBL] [Abstract][Full Text] [Related]
38. The role of efflux transporters on the transport of highly toxic aconitine, mesaconitine, hypaconitine, and their hydrolysates, as determined in cultured Caco-2 and transfected MDCKII cells.
Ye L; Yang X; Yang Z; Gao S; Yin T; Liu W; Wang F; Hu M; Liu Z
Toxicol Lett; 2013 Feb; 216(2-3):86-99. PubMed ID: 23200901
[TBL] [Abstract][Full Text] [Related]
39. Influence of overexpression of efflux proteins on the function and gene expression of endogenous peptide transporters in MDR-transfected MDCKII cell lines.
Wang Z; Pal D; Patel A; Kwatra D; Mitra AK
Int J Pharm; 2013 Jan; 441(1-2):40-9. PubMed ID: 23262422
[TBL] [Abstract][Full Text] [Related]
40. Addressing a vascular endothelium array with blood components using underlying microfluidic channels.
Genes LI; V Tolan N; Hulvey MK; Martin RS; Spence DM
Lab Chip; 2007 Oct; 7(10):1256-9. PubMed ID: 17896007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
